Atomera Prices $125 Million Public Offering Of Common Stock | Latest News RSS feed

Atomera Prices $125 Million Public Offering Of Common Stock - Latest News


Atomera Prices $12.5 Million Public Offering of Common Stock

LOS GATOS, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Atomera Incorporated (Nasdaq: ATOM) today announced that it has priced its underwritten public offering of 2,625,000 shares of its common stock at ... read more

Halozyme Therapeutics Prices Public Offering Of Common Stock

SAN DIEGO, May 18, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today the pricing of its previously announced underwritten public offering of 10,000,000 shares of its ... read more

Homology Medicines Announces Pricing of Public Offering of Common Stock

April 09, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its ... read more

Looking for another news?


Redfin Corporation Prices Public Offerings of Common Stock and Convertible Senior Notes

... the pricing of its concurrent underwritten public offerings of 4,205,510 shares of common stock at a public offering price of $23.50 per share, and $125 million aggregate principal amount of its 1 ... read more


Atomera Announces Closing of Public Offering of Common Stock

Oct. 15, 2018 (GLOBE NEWSWIRE) -- Atomera Incorporated (Nasdaq: ATOM) today announced the closing of its previously announced underwritten public offering of 2,625,000 shares of common stock at a ... read more

TherapeuticsMD Announces Pricing of $125 Million Common Stock Offering

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NYSE MKT: TXMD) today announced the pricing of an underwritten public offering of $125 million of shares of its common stock, offered at a ... read more

Invitae Announces Proposed Public Offering of Common Stock

SAN FRANCISCO, March 4, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $125.0 million ... $18.75 million of shares of ... read more

Alnylam Pharmaceuticals Prices Public Offering of Common Stock

--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the pricing of an underwritten registered public offering of 5,600,000 shares of ... read more

AMAG Pharmaceuticals Announces Proposed Public Offering of $125 Million of Common Stock

AMAG Pharmaceuticals, Inc. AMAG, +3.46% announced today that it has commenced an underwritten public offering of approximately $125 million of shares of its common stock ... and adverse impact on AMAG ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us